Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHP611 in children with metachromatic leukodystrophy
NCT01510028Phase 2Completed
- Sponsor
- Takeda
- Start
- Feb 2012
- Primary completion
- Jan 2017
- Modality
- Replacement Enzymes
- Countries
- 5
01
Overview
A Phase 2 trial of cebsulfase alfa in metachromatic leukodystrophy (MLD), sponsored by Takeda. Started Feb 2012; status: completed.
02
Drugs
cebsulfase alfa
03
Conditions
metachromatic leukodystrophy (MLD)
Beyond the preview
Go deeper on NCT01510028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01510028.